Highlights
- First-half Revenue from the continuing Business rose 2.5% in constant currency to A$250.0 million.
- Cash EBITDA increased 47.1% to A$61.1 million, lifting the cash EBITDA Margin to 24.5%.
- Statutory NPAT rose 85.0% to A$32.0 million, while UPAT increased 18.4% to A$38.8 million.
- Management retained full-year revenue growth guidance of 1% to 2% and an exit run-rate cash EBITDA margin target of 25%.
- Product Investment is being directed toward AI capabilities and further development of the Xplan suite.
Iress (ASX:IRE) is a financial technology company providing software and services to financial advisers, Wealth managers, investment managers, traders and other financial services businesses. Its 2026 half-year result shows a business relying more heavily on efficiency and Recurring Revenue to support Earnings growth while continuing to invest in its core platforms.
Earnings Growth Outpaced Revenue
For the half year, Iress (ASX:IRE) reported revenue of A$250.0 million from its continuing business, up 2.5% in constant currency. Cash EBITDA increased 47.1% to A$61.1 million and the cash EBITDA margin reached 24.5%. Statutory NPAT rose 85.0% to A$32.0 million, while Underlying Profit after tax increased 18.4% to A$38.8 million. The fully franked Interim Dividend was 14.0 cents per share, up 27.3%.
Cost Savings Remain Central to the Earnings Profile
The result reflects a substantial contribution from the cost programme. Iress (ASX:IRE) reported A$31.5 million of annualised cost savings and recurring revenue of 95%. Leverage was reduced to 0.5 times. These measures support cash generation and balance-sheet flexibility, but they also highlight the importance of revenue growth over time, because cost reductions cannot be repeated indefinitely at the same pace.
Guidance Points to Further Margin Improvement
For 2026, management guided to revenue growth of 1% to 2%, cash EBITDA growth of 21% to 26% and UPAT growth of 15% to 21%. The company maintained its target of a 25% cash EBITDA margin on an exit run-rate basis. The guidance therefore continues to rely on operating efficiency and expense discipline, with comparatively modest revenue growth expected across the year.
Xplan and AI Investment Stay in Focus
Iress (ASX:IRE) continues to centre its financial advice offering on Xplan, which supports client management, advice workflows, portfolio administration and related reporting. During the second half, product investment is being directed toward AI capabilities and improvements to the Xplan suite. The commercial contribution from these initiatives has not been quantified, making customer adoption and revenue contribution important measures of progress.
Recurring Revenue Supports Visibility
A recurring revenue share of 95% gives Iress a comparatively predictable revenue base. That profile can support Cash Flow visibility, but growth still depends on customer retention, pricing, product relevance and new business. The company operates in a competitive financial technology market where customers can Demand additional functionality while also scrutinising software costs, placing emphasis on product quality and execution.
Key Insights
The 2026 half-year result shows that Iress (ASX:IRE) has expanded earnings faster than revenue through cost savings and restructuring. The next phase is likely to depend more on maintaining margins while improving the pace of top-line growth. Delivery against the 25% cash EBITDA margin target, progress in Xplan and AI-related product development, and the balance between dividends and reinvestment remain central to the company's operating position.






Please wait processing your request...